Zimmermann Martine

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Ligand Pharmaceuticals Incorporated (LGND)

Transaction date 10 Sep 2026

Sale

Price

238.74

Quantity 57,396 +30.6%

Value US$1,790,310

Ligand Pharmaceuticals Incorporated (LGND)

Transaction date 10 Sep 2026

Proposed sale

Price

26.31

Quantity 82,402

Value US$2,461,040

Ligand Pharmaceuticals Incorporated (LGND)

Transaction date 10 Sep 2026

Proposed sale

Price

430.70

Quantity 39,825

Value US$2,840,995

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2026-09-14	2026-09-10	Ligand Pharmaceuticals Incorporated (LGND)	S Sale	57,396 +30.6% 238.74 US$1,790,310	57,396 +30.6%	238.74	US$1,790,310
2026-09-10	2026-09-10	Ligand Pharmaceuticals Incorporated (LGND)	PrS Proposed sale	82,402 26.31 US$2,461,040	82,402	26.31	US$2,461,040
2026-09-10	2026-09-10	Ligand Pharmaceuticals Incorporated (LGND)	PrS Proposed sale	39,825 430.70 US$2,840,995	39,825	430.70	US$2,840,995

form[method="post"] { display: none !important; }Search companies or insiders: Latest trades English Français Deutsch Español